Trial of Controversial Alzheimer’s Drug Halted After Disappointing Results
Cassava Sciences said that its drug did not significantly reduce [...]
Richard Pazdur, FDA Cancer Chief, Discusses 25 Years of Innovation
Dr. Richard Pazdur for 25 years has overseen innovations in [...]
El medicamento innovador para vencer la adicción: ¿Ozempic?
Los primeros datos sugieren que los fármacos GLP-1, conocidos por [...]
What Drugmakers Did Not Tell Volunteers in Alzheimer’s Trials
Genetic tests showed that certain patients were predisposed to brain [...]
Sammy Basso, Advocate for Progeria Research, Is Dead at 28
One of about 150 people known to have a rare [...]
Why We May Soon Use Ozempic to Treat Addiction
Early data suggests GLP-1 drugs, renowned for their ability to [...]
Officials Cast Doubt on a Dementia Drug, but Human Trials Continue
The S.E.C. alleged shortcomings in research said to support the [...]
F.D.A. Approves a New Antipsychotic Drug
Available antipsychotic treatments work by blocking dopamine receptors. The new [...]
Qué es la rapamicina y por qué se piensa que sirve para mantenerse joven
La rapamicina se suele recetar como inmunosupresor, pero hay quienes [...]
Rapamycin and Anti-Aging: What to Know
Rapamycin is typically prescribed as an immunosuppressive, but off-label users [...]